RBTC

Pesquisar
Publicação semestral da Federação Brasileira de Terapias Cognitivas (FBTC)

Vol. 13 nº 2 - Jul. / Dez.  de 2017

Estudo de Caso

Páginas 147 a 154

Descontinuação de benzodiazepínico no transtorno de pânico: estudo de caso

Discontinuation of benzodiazepine in panic disorder: case study

Autores: Maria Claudia Rodrigues1; Mariana Fortunata Donadon2; Sabrina Kerr Bullamah Correia3; Aline Gerbasi Balestra4; Êdela Aparecida Nicoletti5

PDF Português       Texto em português

Descriptores: Terapia Cognitiva; Transtorno de Pânico; Benzodiazepina.

Keywords: Cognitive Therapy; Panic Disorder; Benzodiazepine.

Abstract:
Despite the effectiveness of the use of benzodiazepines (BZD) in the treatment of Panic Disorder (PD), its discontinuation process can be difficult. Anxious patients may associate the drug with a method of decreasing anxiety symptoms, perceiving it as a safeguard that protects them from possible threats. This case study aimed to report the discontinuation of the use of BZD as safety behavior in a patient with PD, through CBT. In the care of a patient, 28 years old, single, the Beck inventories for depression (BDI), anxiety (BAI) and hopelessness (BHS) were used. We conducted 30 structured sessions in the cognitive-behavioral approach. Treatment followed through cognitive restructuring, through the search for evidence, and gradual exposure in feared situations. As a result, during the treatment process, the patient presented discontinuation of BZD use and a significant improvement in its functionality, breaking the cycle of safety behavior, expanding its social repertoire and reducing anxiety symptoms, with the scores of all inventories have been reduced to zero. The use of CBT provided an important treatment for breaking the cycle of maintaining safety behavior and discontinuing the use of BZD.

 
RBTC RBTC RBTC
Federação Brasileira de Terapias Cognitivas - FBTC
Rua Camargo Paes, 538 - Guanabara - CEP 13073-350, Campinas - SP - Fone: (19) 3241-0032 GN1